|
Spectranetics Corporation |
|
|
9965 Federal Drive
Colorado Springs, CO 80921-3617 USA
phone:(719) 633-8333
fax:1-719-633-8791
|
|
| Symbol |
SPNC |
| Exchange |
Nasdaq |
| Founded |
1984 |
| Employees |
142 |
|
|
| www.spectranetics.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Devices for minimally invasive cardiovascular system surgeries. |
|
| Management |
| Emile J. Geisenheimer, Chairman of the Board, President, Chief Executive Officer; Guy A. Childs, Chief Financial Officer, Vice President; Jonathan W. McGuire, Chief Operating Officer; Roger Wertheimer, Vice President, General Counsel, Secretary, Human Resources; Jason D. Hein Vice President, General Manager, Lead Management; Michael J. Voss > Vice President, General Manager - Vascular Intervention; Wade A. Bowe, Vice President - Product Development and Catheter Manufacturing; Shahriar Matin Vice President - International; Donald C. Fletcher Jr., Vice President - Quality Assurance and Regulatory Compliance; Thomas M. Rasmussen, Vice President - Clinical Affairs |
| |
|
|
|
|
|
|
| Recent Results |
| Revenue for the third quarter of 2006 was a record $16.2 million, up 44% compared with revenue of $11.2 million for the third quarter of 2005. |
| |
|
|
|
|
| Keywords |
| cardiovascular, occlusions, Cardiology, cardiac, heart, coronary, heart, laser, excimer laser, catheter, sheath, minimally invasive, atherectomy, clogged arteries, obstructed arteries |
|
|
|
| Description |
|
Spectranetics develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system, in conjunction with its proprietary excimer laser system. |
|
| Products / Services |
Spectranetics' excimer laser system includes the CVX-300 laser unit and various fiber-optic delivery devices, including disposable catheters and sheaths. The excimer laser system is used in complex atherectomy procedures to open clogged or obstructed arteries in the coronary vascular system. It is also used to remove lead wires from patients with implanted pacemakers or cardioverter defibrillators, which are electronic devices that regulate the heartbeat.
|
|
| Technology / Differentiation |
| Excimer laser technology delivers comparatively cool ultraviolet light in short, controlled energy pulses to ablate or remove blockages. |
|
| Market / Customers |
Coronary Artery Disease occurs when coronary arteries become narrowed or blocked by a buildup of plaque (cholesterol or other materials). When the blockage is severe, the flow of blood and oxygen to your heart muscle is reduced.
|
|
| Competitors / Substitutes / Alternatives |
Boston Scientific Corp., Medtronic, Inc., Pfizer, Inc.
|
|
| Status |
| Spectranetics' excimer laser system is approved in both the United States and Europe for use in multiple, minimally invasive cardiovascular applications. In 2004, Spectranetics received 510(k) clearance from the FDA for its CliRpath laser catheters, which are indicated for use in the endovascular treatment of peripheral artery disease where total obstructions are not crossable with a guidewire. |
|
|
|
| |
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members